TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 11707792

Group type: EXPERIMENTAL
Intervention: Intradermal needles inserted into painful points
Number of subjects: 70

Group type: COMPARATOR
Intervention: Sham treatment (needles inserted into nonpainful points)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 70
Study: 8646220

Group type: EXPERIMENTAL
Intervention: SLE patients
Number of subjects: 25

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 25
Study: 15374366

Group type: EXPERIMENTAL
Intervention: Idebenone (CV-2619) 90 mg/daily
Number of subjects: 104

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 104
Study: 6376128

Group type: EXPERIMENTAL
Intervention: High-dose cis-platinum (100 mg/m2) + adriamycin (60 mg/m2)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Adriamycin (60 mg/m2) + cis-platinum (60 mg/m2)
Number of subjects: 22
Study: 30684199

Group type: EXPERIMENTAL
Intervention: FIT return in year 1
Number of subjects: 5195

Group type: EXPERIMENTAL
Intervention: FIT return in year 2
Number of subjects: 5195

Group type: EXPERIMENTAL
Intervention: FIT return among year 1 adherers in year 2
Number of subjects: 5195

Group type: EXPERIMENTAL
Intervention: FIT return among year 1 non-adherers in year 2
Number of subjects: 5195

Group type: COMPARATOR
Intervention: Comparison of year 1 adherers vs non-adherers in year 2
Number of subjects: 5195

Group type: EXPERIMENTAL
Intervention: Factors associated with higher odds of FIT return
Number of subjects: 5195

Group type: EXPERIMENTAL
Intervention: Neighborhood factor associated with lower FIT return
Number of subjects: 5195
Study: 29421687

Group type: EXPERIMENTAL
Intervention: 2017 ACC/AHA hypertension guidelines (systolic BP ≥130 mm Hg or diastolic BP ≥80 mm Hg)
Number of subjects: 4683

Group type: COMPARATOR
Intervention: JNC 7 hypertension guidelines (systolic BP ≥140 mm Hg or diastolic BP ≥90 mm Hg)
Number of subjects: 4683

Group type: EXPERIMENTAL
Intervention: Comparison of newly reclassified hypertension vs prior guidelines
Number of subjects: 4683
Study: 26401858

Group type: EXPERIMENTAL
Intervention: Local levobupivacaine infiltration (20 mL of levobupivacaine 0.25%)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Intravenous paracetamol (1g before extubation and 5g in the 24 postoperative period)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Intravenous lornoxicam (8 mg before extubation and 8 mg in the 24 postoperative period)
Number of subjects: 60
Study: 23969907

Group type: EXPERIMENTAL
Intervention: Anorganic bone matrix/cell binding peptide (ABM/P‐15)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Guided tissue regeneration (GTR)
Number of subjects: 15
Study: 22480189

Group type: EXPERIMENTAL
Intervention: CBT and Dextroamphetamine
Number of subjects: 48

Group type: COMPARATOR
Intervention: CBT and placebo
Number of subjects: 48
Study: 19195665

Group type: EXPERIMENTAL
Intervention: recombinant human growth hormone (r-hGH)
Number of subjects: 42

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 42
Study: 17404779

Group type: EXPERIMENTAL
Intervention: Melatonin (3mg) administered one hour before bedtime for four weeks
Number of subjects: 18

Group type: COMPARATOR
Intervention: Placebo administered one hour before bedtime for four weeks
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Melatonin (3mg)
Number of subjects: 18
Study: 15161116

Group type: EXPERIMENTAL
Intervention: Methylprednisolone acetate injection
Number of subjects: 60

Group type: COMPARATOR
Intervention: Prednisolone (10-day course)
Number of subjects: 60
Study: 11498721

Group type: EXPERIMENTAL
Intervention: Oral cocaine (62.5, 125, 250 mg/70 kg)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Intravenous cocaine (12.5, 25, 50 mg/70 kg)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Oral cocaine
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Intravenous cocaine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Both oral and intravenous cocaine
Number of subjects: 0
Study: 9919334

Group type: EXPERIMENTAL
Intervention: CPT-11 (irinotecan hydrochloride) at a dose of 120 mg/m2 i.v. over 4 hours on days 1 and 15, and mitomycin-C (MMC) at a dose of 7 mg/m2 i.v. as a bolus on days 1 and 15, given for at least 2 cycles, 4 weeks apart.
Number of subjects: 25
Study: 9114186

Group type: EXPERIMENTAL
Intervention: Oral azithromycin (20 mg/kg) administered as a single dose, one dose a week for 3 weeks, or one dose every 4 weeks for a total of six doses
Number of subjects: 168

Group type: COMPARATOR
Intervention: Topical oxytetracycline/polymyxin eye ointment (once daily for 5 days every 4 weeks; total of six treatment cycles)
Number of subjects: 168
Study: 2667325

Group type: EXPERIMENTAL
Intervention: High-dose methotrexate pretreatment at 0 h before 5-FU
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: High-dose methotrexate pretreatment at 3 h before 5-FU
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: High-dose methotrexate followed by 5-FU (both doses: 1,000 mg/m2)
Number of subjects: 32
Study: 8814

Group type: EXPERIMENTAL
Intervention: Chlorpromazine (CPZ) treatment after placebo
Number of subjects: 18

Group type: COMPARATOR
Intervention: Acute CPZ treatment
Number of subjects: 18

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study: 31772083

Group type: EXPERIMENTAL
Intervention: Atosiban
Number of subjects: 1514

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1514
Study: 27657350

Group type: EXPERIMENTAL
Intervention: Magnetic field therapy (MFT)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 44
Study: 25024135

Group type: EXPERIMENTAL
Intervention: Minimalist shoe
Number of subjects: 18

Group type: COMPARATOR
Intervention: Standard shoe
Number of subjects: 18
Study: 24259042

Group type: EXPERIMENTAL
Intervention: Women with acute heart failure
Number of subjects: 2033

Group type: COMPARATOR
Intervention: Men with acute heart failure
Number of subjects: 2033
Study: 21975668

Group type: EXPERIMENTAL
Intervention: Growth hormone (GH) 0.14 mg/kg/d for 4 months
Number of subjects: 14

Group type: COMPARATOR
Intervention: Control group (CTR) without GH for 4 months, followed by GH for 4 months
Number of subjects: 14

Group type: COMPARATOR
Intervention: Control group (CTR) after GH treatment
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Growth hormone (GH) after discontinuation
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 14
Study: 19571282

Group type: COMPARATOR
Intervention: Enalapril (20 mg daily)
Number of subjects: 285

Group type: COMPARATOR
Intervention: Losartan (100 mg daily)
Number of subjects: 285

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 285
Study: 17078448

Group type: EXPERIMENTAL
Intervention: He‐Ne laser auricular irradiation plus body acupuncture
Number of subjects: 68

Group type: COMPARATOR
Intervention: Body acupuncture only
Number of subjects: 68
Study: 14769732

Group type: EXPERIMENTAL
Intervention: tgAAVCF
Number of subjects: 42

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 42
Study: 11301406

Group type: EXPERIMENTAL
Intervention: Oral ciprofloxacin 20 mg/kg/day p.o. every 12 hours for 6 days
Number of subjects: 87

Group type: COMPARATOR
Intervention: Intravenous ceftriaxone plus amikacin for 2 days more followed by cefixime 8 mg/kg/day p.o. every 24 hours for 4 additional days
Number of subjects: 87
Study: 9253549

Group type: EXPERIMENTAL
Intervention: West Indian infants
Number of subjects: 27459

Group type: EXPERIMENTAL
Intervention: African infants
Number of subjects: 27459

Group type: COMPARATOR
Intervention: European white infants
Number of subjects: 27459
Study: 8275912

Group type: EXPERIMENTAL
Intervention: Paroxetine (20 mg o.d.)
Number of subjects: 83

Group type: EXPERIMENTAL
Intervention: Clomipramine (increasing from 20 mg o.d. to 20 mg tds)
Number of subjects: 83

Group type: COMPARATOR
Intervention: Placebo (used to maintain blinding)
Number of subjects: 83
Study: 3541622

Group type: EXPERIMENTAL
Intervention: 3 mg of percutaneous estradiol
Number of subjects: 57

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 57
Study: 30563538

Group type: EXPERIMENTAL
Intervention: βA (2.4 g·d-1, βA1)
Number of subjects: 27

Group type: COMPARATOR
Intervention: Matched total βA (4.8 g on alternate days, βA2)
Number of subjects: 27

Group type: COMPARATOR
Intervention: Cornflour placebo (2.4 g·d-1, PL)
Number of subjects: 27
Study: 28247635

Group type: EXPERIMENTAL
Intervention: Basic therapy combined with 10 treatment sessions of hypercapnic hypoxia using a respiratory device
Number of subjects: 37

Group type: COMPARATOR
Intervention: Basic therapy only
Number of subjects: 37
Study: 25914475

Group type: EXPERIMENTAL
Intervention: Flupentixol-melitracen plus omeprazole (Group 1)
Number of subjects: 262

Group type: EXPERIMENTAL
Intervention: Flupentixol-melitracen plus omeprazole (Group 2)
Number of subjects: 262

Group type: EXPERIMENTAL
Intervention: Flupentixol-melitracen plus omeprazole (Group 3)
Number of subjects: 262

Group type: COMPARATOR
Intervention: Omeprazole alone (Group 4)
Number of subjects: 262
Study: 22392419

Group type: EXPERIMENTAL
Intervention: Anticoagulation Management Service (AMS)
Number of subjects: 62

Group type: COMPARATOR
Intervention: Primary Care Physician (PCP)
Number of subjects: 62

Group type: COMPARATOR
Intervention: Both groups (AMS and PCP)
Number of subjects: 62
Study: 20494332

Group type: EXPERIMENTAL
Intervention: Anterior colporrhaphy with mesh
Number of subjects: 202

Group type: COMPARATOR
Intervention: Anterior colporrhaphy without mesh (control group)
Number of subjects: 202

Group type: EXPERIMENTAL
Intervention: Mesh group
Number of subjects: 202

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 202
Study: 18378994

Group type: EXPERIMENTAL
Intervention: Integrated multidisciplinary diagnostic facility
Number of subjects: 230

Group type: COMPARATOR
Intervention: Treatment as usual
Number of subjects: 230
Study: 15832577

Group type: EXPERIMENTAL
Intervention: Micro-CT analysis of cancellous bone fragments from distal radius fracture zones in osteoporosis
Number of subjects: 0

Group type: COMPARATOR
Intervention: Micro-CT analysis of cancellous bone fragments from distal radius fracture zones in non-osteoporotic patients
Number of subjects: 0
Study: 12435256

Group type: EXPERIMENTAL
Intervention: Hormone Replacement Therapy (HRT) - 0.625 mg/d of conjugated equine estrogen (plus 2.5 mg/d of medroxyprogesterone acetate for women who had not had a hysterectomy)
Number of subjects: 423

Group type: EXPERIMENTAL
Intervention: Antioxidant vitamins - 400 IU of vitamin E twice daily plus 500 mg of vitamin C twice daily
Number of subjects: 423

Group type: COMPARATOR
Intervention: HRT placebo
Number of subjects: 423

Group type: COMPARATOR
Intervention: Vitamin placebo
Number of subjects: 423

Group type: EXPERIMENTAL
Intervention: Combined outcomes for HRT
Number of subjects: 423

Group type: EXPERIMENTAL
Intervention: Combined outcomes for vitamins
Number of subjects: 423
Study: 10601537

Group type: EXPERIMENTAL
Intervention: High fat enteral nutrition (67% of non-protein energy intake)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Normal fat enteral nutrition (40% of non-protein energy intake)
Number of subjects: 8
Study: 7851545

Group type: EXPERIMENTAL
Intervention: Recombinant interleukin-2 (rIL-2)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study: 1779605

Group type: EXPERIMENTAL
Intervention: Immunochemotherapy
Number of subjects: 51

Group type: COMPARATOR
Intervention: Chemotherapy alone
Number of subjects: 51
Study: 7025877

Group type: EXPERIMENTAL
Intervention: Fentanyl 60 microgram kg‐1 and nitrous oxide in oxygen
Number of subjects: 20

Group type: COMPARATOR
Intervention: Etomidate 0.3 mgkg‐1 and nitrous oxide in oxygen plus halothane
Number of subjects: 20
Study: 31889671

Group type: EXPERIMENTAL
Intervention: Short anaesthetic‐ECT time interval
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Long anaesthetic‐ECT time interval
Number of subjects: 54

Group type: COMPARATOR
Intervention: Normal ventilation during anaesthetic induction
Number of subjects: 54

Group type: COMPARATOR
Intervention: Hyperventilation during anaesthetic induction
Number of subjects: 54
Study: 30945297

Group type: EXPERIMENTAL
Intervention: Pomegranate seed oil (PSO) - 1 g daily for 8 weeks
Number of subjects: 52

Group type: COMPARATOR
Intervention: Placebo (paraffin) - same amounts as PSO
Number of subjects: 52
Study: 27569662

Group type: EXPERIMENTAL
Intervention: Home-based pre-operative inspiratory muscle training programme
Number of subjects: 235

Group type: COMPARATOR
Intervention: Usual care group
Number of subjects: 235
Study: 25134043

Group type: EXPERIMENTAL
Intervention: Sexual Motives for Drinking (SMDs) measure
Number of subjects: 0
Study: 23931458

Group type: EXPERIMENTAL
Intervention: Image agreement assessment using ClearCanvas™ by three fellowship‐trained specialists in uveitis.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Image agreement assessment among the three reviewers.
Number of subjects: 0
Study: 21544980

Group type: EXPERIMENTAL
Intervention: Filgrastim (G-CSF) administration
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (children with inflammatory state)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (healthy children)
Number of subjects: 0
Study: 19178619

Group type: COMPARATOR
Intervention: Coping (alumina-supported) margins
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Porcelain-butt (all-porcelain) margins
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Comparison of coping and porcelain-butt margins
Number of subjects: 16
Study: 17446439

Group type: EXPERIMENTAL
Intervention: Ischemic preconditioning (IPC) - upper limb ischemia (cuff inflation of over 200 mm Hg for 5 minutes) 6 times a day for 1 month
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: N(G)-monomethyl-L-arginine (nitric oxide synthase inhibitor)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Contralateral arms of subjects that received the IPC stimulus
Number of subjects: 30
Study: 15121945

Group type: EXPERIMENTAL
Intervention: Zinc supplementation (5 mg of zinc sulfate daily)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Control group (micronutrient mix without zinc)
Number of subjects: 200
Study: 12516191

Group type: EXPERIMENTAL
Intervention: Benzylpenicillin (1.0 g four times daily, i/v) combined with ciprofloxacin (0.5 g twice daily, per os)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Ciprofloxacin (0.5 g twice daily, per os)
Number of subjects: 40
Study: 9695301

Group type: EXPERIMENTAL
Intervention: Benzathine penicillin G (BPG) prophylaxis every 3 weeks as a single intramuscular injection of 1.2 million units for children over 27 kg, and a half dose for those 27 kg or less.
Number of subjects: 160

Group type: COMPARATOR
Intervention: Control group (no BPG prophylaxis).
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: BPG prophylaxis.
Number of subjects: 160
Study: 7857351

Group type: EXPERIMENTAL
Intervention: Pidotimod 800 mg/die for 60 days
Number of subjects: 181

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 181
Study: 2751741

Group type: EXPERIMENTAL
Intervention: Antacid (Trigastril) with 50 mg pirenzepine
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo gel with 50 mg pirenzepine
Number of subjects: 10
Study: 797592

Group type: EXPERIMENTAL
Intervention: Betamethasone dipropionate cream (Diprosone)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Locacorten 0.02% cream
Number of subjects: 60
Study: 31478335

Group type: EXPERIMENTAL
Intervention: Gemigliptin 50 mg once daily
Number of subjects: 283

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 283
Study: 31347742

Group type: EXPERIMENTAL
Intervention: LigaSure Small Jaw (LSJ)
Number of subjects: 420

Group type: COMPARATOR
Intervention: Clamp-and-tie technique (C)
Number of subjects: 420
Study: 28985799

Group type: EXPERIMENTAL
Intervention: Augmented reality simulator training (Group 2)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Conventional teaching (Group 1)
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Conventional teaching (Group 1) after AR training
Number of subjects: 28
Study: 25178520

Group type: EXPERIMENTAL
Intervention: Long-term group psychotherapy (LTG) - 80 weekly sessions of 90 min each
Number of subjects: 167

Group type: COMPARATOR
Intervention: Short-term group psychotherapy (STG) - 20 weekly sessions of 90 min each
Number of subjects: 167
Study: 23434621

Group type: EXPERIMENTAL
Intervention: Advisa MRI pacing system
Number of subjects: 263
Study: 21453230

Group type: EXPERIMENTAL
Intervention: Steroid-free regimen (tacrolimus, mycophenolate mofetil, steroids for only 3 days)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Steroid-maintenance regimen (tacrolimus, mycophenolate mofetil, steroids on a maintenance basis)
Number of subjects: 100
Study: 18079005

Group type: EXPERIMENTAL
Intervention: Peritonsillar injection of tramadol (2 mg/kg)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Intramuscular analgesia with tramadol (2 mg/kg)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 45
Study: 15922513

Group type: EXPERIMENTAL
Intervention: Negative affect word prime
Number of subjects: 0

Group type: COMPARATOR
Intervention: Positive word prime
Number of subjects: 0

Group type: COMPARATOR
Intervention: Neutral word prime
Number of subjects: 0
Study: 12829675

Group type: EXPERIMENTAL
Intervention: Temozolomide 200 mg/m2 every 8 hours for five doses
Number of subjects: 181

Group type: EXPERIMENTAL
Intervention: Temozolomide 200 mg/m2 daily for days 1 to 5 plus interferon alfa‐2b 5 MU subcutaneously three times a week
Number of subjects: 181

Group type: EXPERIMENTAL
Intervention: Temozolomide 150 mg/m2 (increased after one cycle to 200 mg/m2) daily on days 1 to 5 plus thalidomide 100 mg daily days 1 to 28
Number of subjects: 181
Study: 11205963

Group type: EXPERIMENTAL
Intervention: Enalapril 10 mg
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Enalapril 20 mg
Number of subjects: 19

Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 19
Study: 8804096

Group type: EXPERIMENTAL
Intervention: Regular (collinear) triplets
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Generic (not regular) triplets
Number of subjects: 0
Study: 1466441

Group type: EXPERIMENTAL
Intervention: Hudson mask (48 l.min‐1)
Number of subjects: 138

Group type: COMPARATOR
Intervention: Magill system (100 ml.kg‐1.min‐1)
Number of subjects: 138
Study: 6689974

Group type: EXPERIMENTAL
Intervention: dextran 70
Number of subjects: 116

Group type: COMPARATOR
Intervention: low-dose heparin combined with dihydroergotamine (HDHE)
Number of subjects: 116
Study: 27898516

Group type: EXPERIMENTAL
Intervention: Comfilcon A soft toric lens for two weeks, then LRGP lenses (Boston XO, 14.3 mm diameter)
Number of subjects: 36

Group type: COMPARATOR
Intervention: LRGP lenses (Boston XO, 14.3 mm diameter) for two weeks, then Comfilcon A soft toric lens
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Both lens types (soft toric and LRGP)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: LRGP lenses
Number of subjects: 36
Study: 26490089

Group type: EXPERIMENTAL
Intervention: benidipine-thiazide
Number of subjects: 2983

Group type: COMPARATOR
Intervention: benidipine-β-blocker
Number of subjects: 2983

Group type: COMPARATOR
Intervention: benidipine-ARB
Number of subjects: 2983
Study: 25241527

Group type: EXPERIMENTAL
Intervention: Minimally invasive thoracic surgery
Number of subjects: 75

Group type: COMPARATOR
Intervention: Conventional thoracotomy
Number of subjects: 75
Study: 22653220

Group type: EXPERIMENTAL
Intervention: Eicosapentaenoic acid (EPA)
Number of subjects: 13901

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 13901

Group type: EXPERIMENTAL
Intervention: DHA-high tertile
Number of subjects: 13901

Group type: EXPERIMENTAL
Intervention: EPA tertiles
Number of subjects: 13901
Study: 19496972

Group type: EXPERIMENTAL
Intervention: Metformin for 6 months
Number of subjects: 42

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 42
Study: 18519478

Group type: EXPERIMENTAL
Intervention: Immediate-results condition (pediatricians received screening results just before encounters)
Number of subjects: 878

Group type: COMPARATOR
Intervention: Delayed-results condition (pediatricians received screening results 2 to 3 business days later)
Number of subjects: 878
Study: 15851888

Group type: EXPERIMENTAL
Intervention: Nerve block anesthesia (0.75% ropivacaine)
Number of subjects: 50

Group type: COMPARATOR
Intervention: General anesthesia (fast‐track general anesthesia followed by bupivacaine (0.25%) wound infiltration)
Number of subjects: 50
Study: 14636900

Group type: EXPERIMENTAL
Intervention: Low-dose dobutamine echocardiography (up to 10 microg/kg/min)
Number of subjects: 425
Study: 11027441

Group type: EXPERIMENTAL
Intervention: SPF 10 sunscreen
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: SPF 30 sunscreen
Number of subjects: 58
Study: 9056614

Group type: EXPERIMENTAL
Intervention: Perindopril (4 mg for 15 days)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study: 8365524

Group type: EXPERIMENTAL
Intervention: Vaginal progesterone (25 mg b.i.d.) during cycle days 16-24 for 10 months
Number of subjects: 135

Group type: COMPARATOR
Intervention: Placebo during cycle days 16-24 for 10 months
Number of subjects: 135

Group type: EXPERIMENTAL
Intervention: Vaginal progesterone (25 mg b.i.d.)
Number of subjects: 135

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 135
Study: 3805300

Group type: EXPERIMENTAL
Intervention: Stress inoculation therapy
Number of subjects: 26

Group type: COMPARATOR
Intervention: Medication therapy
Number of subjects: 26

Group type: COMPARATOR
Intervention: Combination of stress inoculation and medication therapy
Number of subjects: 26
Study: 30197313

Group type: EXPERIMENTAL
Intervention: Continuous lumbar plexus block (CLPB)
Number of subjects: 60

Group type: COMPARATOR
Intervention: PCIA
Number of subjects: 60
Study: 26578361

Group type: EXPERIMENTAL
Intervention: Continuous ultrasound therapy (0.4 W/cm(2 SATA))
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Pulsed ultrasound therapy (20% duty cycle, 0.08 W/cm(2 SATA))
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Continuous ultrasound therapy (0.4 W/cm(2 SATA)) after COX inhibition (aspirin)
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Pulsed ultrasound therapy (20% duty cycle, 0.08 W/cm(2 SATA)) after COX inhibition (aspirin)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Placebo (equipment power off)
Number of subjects: 42
Study: 24625149

Group type: EXPERIMENTAL
Intervention: Enclosed tobacco display
Number of subjects: 1216

Group type: COMPARATOR
Intervention: Warning sign (present vs absent)
Number of subjects: 1216